Eudaimonia Partners LLC cut its holdings in Colgate-Palmolive (NYSE:CL – Get Rating) by 60.2% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 3,204 shares of the company’s stock after selling 4,847 shares during the quarter. Eudaimonia Partners LLC’s holdings in Colgate-Palmolive were worth $225,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Brown Advisory Inc. boosted its holdings in Colgate-Palmolive by 3.8% in the second quarter. Brown Advisory Inc. now owns 171,321 shares of the company’s stock valued at $14,106,000 after acquiring an additional 6,275 shares during the last quarter. Walleye Capital LLC bought a new position in Colgate-Palmolive in the second quarter valued at about $1,588,000. First National Trust Co boosted its holdings in Colgate-Palmolive by 4.8% in the third quarter. First National Trust Co now owns 5,411 shares of the company’s stock valued at $381,000 after acquiring an additional 249 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund boosted its holdings in Colgate-Palmolive by 15.1% in the second quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 28,628 shares of the company’s stock valued at $2,294,000 after acquiring an additional 3,750 shares during the last quarter. Finally, Cribstone Capital Management LLC boosted its holdings in Colgate-Palmolive by 6.0% in the second quarter. Cribstone Capital Management LLC now owns 8,693 shares of the company’s stock valued at $697,000 after acquiring an additional 492 shares during the last quarter. 77.63% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on CL shares. The Goldman Sachs Group reduced their target price on Colgate-Palmolive from $91.00 to $81.00 and set a “buy” rating on the stock in a report on Monday, October 10th. Credit Suisse Group reduced their target price on Colgate-Palmolive from $88.00 to $85.00 and set an “outperform” rating on the stock in a report on Tuesday, October 18th. Deutsche Bank Aktiengesellschaft raised their target price on Colgate-Palmolive from $85.00 to $87.00 and gave the stock a “buy” rating in a report on Tuesday, December 6th. UBS Group reduced their target price on Colgate-Palmolive from $90.00 to $80.00 in a report on Thursday, October 13th. Finally, Wolfe Research started coverage on Colgate-Palmolive in a report on Monday, November 21st. They set a “market perform” rating on the stock. Eight analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $83.58.
Colgate-Palmolive Stock Up 0.6 %
Colgate-Palmolive (NYSE:CL – Get Rating) last posted its quarterly earnings results on Friday, October 28th. The company reported $0.74 earnings per share for the quarter, hitting the consensus estimate of $0.74. The firm had revenue of $4.46 billion for the quarter, compared to analyst estimates of $4.47 billion. Colgate-Palmolive had a return on equity of 304.29% and a net margin of 10.87%. The business’s quarterly revenue was up .9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.81 EPS. On average, analysts predict that Colgate-Palmolive will post 2.97 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, February 14th. Shareholders of record on Monday, January 23rd will be given a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 2.48%. The ex-dividend date of this dividend is Friday, January 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 81.74%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.
- Get a free copy of the StockNews.com research report on Colgate-Palmolive (CL)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.